The management of anticoagulation in patients with prosthetic heart valves undergoing non-cardiac operations
Open Access
- 1 July 1995
- journal article
- research article
- Published by Oxford University Press (OUP)
- Vol. 71 (837), 390-392
- https://doi.org/10.1136/pgmj.71.837.390
Abstract
Prosthetic valve thrombogenicity and bleeding complications associated with life-long anticoagulation are constant potential causes of morbidity and mortality following prosthetic valve implantation. The conflict between over- and under-anticoagulation is even more of a problem when other surgical interventions are required. Very few clinical trials have addressed this issue. We propose some guidelines based on the concept of risk-adjusted intensity of anticoagulation but stress the need for caution with interpretation of these recommendations.Keywords
This publication has 10 references indexed in Scilit:
- Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?1993
- Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses.1993
- The pharmacology of oral anticoagulants: implications for therapy.1993
- Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1990
- Thrombotic and Bleeding Complications of Prosthetic Heart ValvesThe Annals of Thoracic Surgery, 1987
- Recurrent systemic embolic events with valve prosthesisEuropean Heart Journal, 1984
- The management of anticoagulation during noncardiac operations in patients with prosthetic heart valvesAmerican Heart Journal, 1978
- Discontinuing Anticoagulant Therapy in Surgical Patients With Cardiac Valve ProsthesesPublished by American Medical Association (AMA) ,1978
- Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valvesThe Journal of Thoracic and Cardiovascular Surgery, 1976
- Systemic Embolism in Mitral StenosisBMJ, 1964